The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in ...
A drug that targets the coronavirus’ entry point into cells could protect against the infection as new variants emerge. Existing treatments and vaccines work against SARS-CoV-2 itself, raising the ...
Rapid person-to-person transmission seen in SARS-like virus The new human coronavirus, hCoV-EMC, identified earlier this year in the Middle East may use a receptor conserved between bats, pigs and ...
University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body. This protein, the leucine-rich ...
It is known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative microbe for coronavirus disease 19 (COVID-19), is highly contagious. Although vaccines are effective in ...
In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the ...
BOSTON-- Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results